Faulty hip implants: No tinkering with compensation formula despite fresh appeal

Expert committee chairman asks Johnson and Johnson’s faulty hip implant victims to approach court

Expert team meets Johnson & Johnson victims; may skirt base amount

Company representatives present its side too

Bedaquiline patent win is a half victory

India’s ability to eliminate its huge TB burden by 2025 will be a test of both its patent laws and healthcare policy

Johnson & Johnson to pay $417 million in case linking its talc to ovarian cancer

Use of the Johnson's Baby Powder for feminine hygiene allegedly causes ovarian cancer, but the company denies it

Bedaquiline and India's patent law

Opposition to the new patent claims on the Johnson & Johnson drug is a test of how well the rules against evergreening are working

Delhi High Court orders J&J to pay 67 hip implant patients Rs 25 lakh each

Activists term compensation as eyewash, say the case is still on

Missouri court orders Johnson & Johnson to pay $72 million to family of consumer

Woman had reportedly died from cancer developed by regular use of company’s talcum powder

COVID-19 vaccines produce T-cell immunity that lasts and works against virus variants

Vaccines train the immune system to recognise and respond to a particular pathogen, without first having to be infected by it

COVID-19 vaccines: Is foreign good for India

The decision to allow foreign vaccines in India may not take plug the current shortage  

Johnson & Johnson recalls 33,000 talcum powder bottles after asbestos traces found

The multinational corporation says it will conduct an investigation parallel to the one being conducted by US FDA

Trade barriers, raw material scarcity can dent hopes for 10 billion COVID-19 vaccines in production

Experts warned of short supply of crucial raw materials; late delivery of bio-reactor giant plastic bags can set back production by weeks, …

March against asbestos

Though its use is banned in most countries, the asbestos industry continues to thrive at the cost of putting millions of people at risk

Making COVID-19 vaccines in Africa: Advances and sustainability issues

Demand, market for locally produced vaccines critical for sustainability of 15 COVID-19 vaccines manufacturing facilities

Effectiveness of COVID-19 vaccines against infection, severe disease declined with new variants; here's how

AstraZeneca vaccine provided least protection against infection, showed most rapid decline

COVID-19 vaccines for all: Decoding global tenders by states

At least a dozen Indian states have floated or will float tenders for procuring vaccines and will also bear the cost

Experts suggest updating vaccines for new variants. How does it work & what are the challenges?

It is easier to update certain vaccine platforms than others, say experts

Medicines Pool Swirls

Drug companies are slowly joining the UN effort to offer life-saving patented medicines to poor countries but the terms are sometimes restrictive

COVID-19 in Africa: The pain of getting the jab

The COVAX Facility and the African Union are struggling to bring some relief to Africa which has been suffering from vaccine apartheid

Big US firms form group to buy more renewable energy at competitive prices

Companies including Bloomberg, General motors sign Renewable Energy Buyers' Principles to meet power purchase goals